Brian Gazaille - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Brian Gazaille's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Brian Gazaille
Verified
Managing Editor, BioProcess International Magazine
Eugene
Beats
viral vectors,Biopharmaceutical development and manufacturing vaccines, cell and gene therapies mRNA, antibodies mAbs
Useless controversies
Content
By Ilona Baraniak-Lang, Anna-Lena Amend, Brian Gazaille Verified, Raymond P. Goodrich| BioProcess International Magazine Verified Innovation in vaccine manufacturing did not stop with the approval of the world’s first messenger RNA (mRNA)–based products during the COVID-19 pandemic. Much to the contrary, vaccine developers are building upon recent successes with mRNA and other modalities to address diseases that have been difficult to prevent and treat. Articles in this month’s featured report highlight pathways that developers are investigating to engage recipient immune systems.
By Brian Gazaille Verified, Toshio Ariyasu, Kanso Iwaki| BioProcess International Magazine Verified Sucrose has a long and successful history as a pharmaceutical excipient. As I learned from Toshio Ariyasu (senior scientist) and Kanso Iwaki (pharmaceutical business development advisor) of Nagase Viita, that saccharide has been used not only in oral formulations of small-molecule drugs, but also in biopharmaceuticals formulated for parenteral administration.
By Cheryl Scott Verified, Dana Cipriano, Brian Gazaille Verified, Derek Ryan| BioProcess International Magazine Verified Potency. Stability. Product characterization. Bioassays and other analytical methods provide a foundation of information on which biopharmaceutical development and manufacturing are built. Companies working with proteins, gene therapies, and other biological modalities are increasingly interested in taking a platform approach. They would love to have a set of go-to methods and protocols that can be applied across similar products in their portfolios.
Company Info
BioProcess International Magazine
BioProcess International is a media and events company dedicated to the biopharmaceutical industry, operating under Informa Connect. It serves as a vital resource for professionals involved in biotherapeutic and biodiagnostic development, providing peer-reviewed insights through its monthly magazine. The company focuses on process development, scale-up, and manufacturing challenges within the global industrial biotherapeutic community. BioProcess International offers a controlled-circulation magazine that delivers updates on bioprocessing technologies, regulatory trends, and manufacturing best practices. It also organizes significant conferences, such as the BioProcess International Conference & Exhibition and BPI West, which center on biologics, cell therapies, and gene therapies. The company fosters community engagement by facilitating knowledge exchange through expert-led sessions, networking opportunities, and case studies at its events.
Eugene, United States
+1 508-616-5550
Founded: 2002